228 related articles for article (PubMed ID: 36416233)
1. Engineering Biomimetic Trogocytosis with Farnesylated Chemically Self-Assembled Nanorings.
Wang Y; Rozumalski L; Kilic O; Lichtenfels C; Petersberg J; Distefano MD; Wagner CR
Biomacromolecules; 2022 Dec; 23(12):5018-5035. PubMed ID: 36416233
[TBL] [Abstract][Full Text] [Related]
2. Engineering reversible cell-cell interactions using enzymatically lipidated chemically self-assembled nanorings.
Wang Y; Kilic O; Csizmar CM; Ashok S; Hougland JL; Distefano MD; Wagner CR
Chem Sci; 2020 Oct; 12(1):331-340. PubMed ID: 34168743
[TBL] [Abstract][Full Text] [Related]
3. Chemically self-assembled antibody nanorings (CSANs): design and characterization of an anti-CD3 IgM biomimetic.
Li Q; So CR; Fegan A; Cody V; Sarikaya M; Vallera DA; Wagner CR
J Am Chem Soc; 2010 Dec; 132(48):17247-57. PubMed ID: 21077608
[TBL] [Abstract][Full Text] [Related]
4. Engineering Reversible Cell-Cell Interactions with Lipid Anchored Prosthetic Receptors.
Csizmar CM; Petersburg JR; Hendricks A; Stern LA; Hackel BJ; Wagner CR
Bioconjug Chem; 2018 Apr; 29(4):1291-1301. PubMed ID: 29537253
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Evaluation of Site-Specifically PEGylated Chemically Self-Assembled Protein Nanostructures.
Shah R; Petersburg J; Gangar AC; Fegan A; Wagner CR; Kumarapperuma SC
Mol Pharm; 2016 Jul; 13(7):2193-203. PubMed ID: 26985775
[TBL] [Abstract][Full Text] [Related]
6. Targeted Drug Delivery by MMAE Farnesyl-Bioconjugated Multivalent Chemically Self-Assembled Nanorings Induces Potent Receptor-Dependent Immunogenic Cell Death.
Wang Y; Kilic O; Rozumalski L; Distefano MD; Wagner CR
Bioconjug Chem; 2024 May; 35(5):582-592. PubMed ID: 38701361
[TBL] [Abstract][Full Text] [Related]
7. Chemically self-assembled antibody nanostructures as potential drug carriers.
Fegan A; Kumarapperuma SC; Wagner CR
Mol Pharm; 2012 Nov; 9(11):3218-27. PubMed ID: 23013206
[TBL] [Abstract][Full Text] [Related]
8. Targeted delivery of antisense oligonucleotides by chemically self-assembled nanostructures.
Gangar A; Fegan A; Kumarapperuma SC; Huynh P; Benyumov A; Wagner CR
Mol Pharm; 2013 Sep; 10(9):3514-8. PubMed ID: 23829765
[TBL] [Abstract][Full Text] [Related]
9. Reversible re-programing of cell-cell interactions.
Gabrielse K; Gangar A; Kumar N; Lee JC; Fegan A; Shen JJ; Li Q; Vallera D; Wagner CR
Angew Chem Int Ed Engl; 2014 May; 53(20):5112-6. PubMed ID: 24700601
[TBL] [Abstract][Full Text] [Related]
10. The Role of Trogocytosis in the Modulation of Immune Cell Functions.
Miyake K; Karasuyama H
Cells; 2021 May; 10(5):. PubMed ID: 34069602
[TBL] [Abstract][Full Text] [Related]
11. Multivalent, Bispecific αB7-H3-αCD3 Chemically Self-Assembled Nanorings Direct Potent T Cell Responses against Medulloblastoma.
Mews EA; Beckmann P; Patchava M; Wang Y; Largaespada DA; Wagner CR
ACS Nano; 2022 Aug; 16(8):12185-12201. PubMed ID: 35876221
[TBL] [Abstract][Full Text] [Related]
12. Eradication of Established Tumors by Chemically Self-Assembled Nanoring Labeled T Cells.
Petersburg JR; Shen J; Csizmar CM; Murphy KA; Spanier J; Gabrielse K; Griffith TS; Fife B; Wagner CR
ACS Nano; 2018 Jul; 12(7):6563-6576. PubMed ID: 29792808
[TBL] [Abstract][Full Text] [Related]
13. DNA nanostructures interacting with lipid bilayer membranes.
Langecker M; Arnaut V; List J; Simmel FC
Acc Chem Res; 2014 Jun; 47(6):1807-15. PubMed ID: 24828105
[TBL] [Abstract][Full Text] [Related]
14. Anti-EGFR Fibronectin Bispecific Chemically Self-Assembling Nanorings (CSANs) Induce Potent T Cell-Mediated Antitumor Responses and Downregulation of EGFR Signaling and PD-1/PD-L1 Expression.
Kilic O; Matos de Souza MR; Almotlak AA; Wang Y; Siegfried JM; Distefano MD; Wagner CR
J Med Chem; 2020 Sep; 63(18):10235-10245. PubMed ID: 32852209
[TBL] [Abstract][Full Text] [Related]
15. Eradication of Heterogeneous Tumors by T Cells Targeted with Combination Bispecific Chemically Self-assembled Nanorings.
Petersburg J; Vallera DA; Wagner CR
Mol Cancer Ther; 2023 Mar; 22(3):371-380. PubMed ID: 36548194
[TBL] [Abstract][Full Text] [Related]
16. Trogocytosis between Non-Immune Cells for Cell Clearance, and among Immune-Related Cells for Modulating Immune Responses and Autoimmunity.
Li KJ; Wu CH; Lu CH; Shen CY; Kuo YM; Tsai CY; Hsieh SC; Yu CL
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668117
[TBL] [Abstract][Full Text] [Related]
17. Membrane-fusogenic biomimetic particles: a new bioengineering tool learned from nature.
Kong H; Yi K; Zheng C; Lao YH; Zhou H; Chan HF; Wang H; Tao Y; Li M
J Mater Chem B; 2022 Sep; 10(36):6841-6858. PubMed ID: 35781483
[TBL] [Abstract][Full Text] [Related]
18. Spontaneous structural transition in phospholipid-inspired aromatic phosphopeptide nanostructures.
Pellach M; Atsmon-Raz Y; Simonovsky E; Gottlieb H; Jacoby G; Beck R; Adler-Abramovich L; Miller Y; Gazit E
ACS Nano; 2015; 9(4):4085-95. PubMed ID: 25802000
[TBL] [Abstract][Full Text] [Related]
19. Decentralized manufacturing for biomimetics through cooperation of digitization and nanomaterial design.
Xiao M; Yang H; Xiao Q; Zhang H; Chen X
Nanoscale; 2019 Oct; 11(41):19179-19189. PubMed ID: 31281908
[TBL] [Abstract][Full Text] [Related]
20. Self-assembled peptide nanoarchitectures: applications and future aspects.
Sharma PP; Rathi B; Rodrigues J; Gorobets NY
Curr Top Med Chem; 2015; 15(13):1268-89. PubMed ID: 25850932
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
